Jill Merle

“Former COO of Hamilton Lane’s direct investment unit (appointed in 2007) who helped professionalize operations in an early-stage environment—implementing DealCloud, revamping investment committee materials, and creating valuation governance. Known for pairing process/technology upgrades with culture repair through high-touch communication and transparent leadership.”

Sammy Datwani

Screened

Executive biotech leader specializing in microfluidics, diagnostics, and life science tools

Pleasanton, CA25y exp

“Biotech founder building a de-novo protein sequencing company, originally incubated by Versant Ventures and now focused on life science tools and clinical diagnostics. Has raised capital from institutional VCs, strategic investors, and a foundation, and brings unusual ecosystem depth through mentoring at IndieBio, Berkeley SkyDeck, and Biotools Innovator, plus board service with Life Science Angels and VC diligence advisory work.”

“Fractional CTO and AI/ML consultant at Clover Health with deep insurance domain experience (15 years as CTO/CISO/AI). Has spent significant time in PE/VC-backed environments (including Aquiline Capital Partners and Apollo Group), designing and engineering platforms while delivering against budgets, audits, and regulatory compliance. Recently helped build an insurance startup (2020–2025) and is now seeking a full-time role at a startup.”